Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic rest...
Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study
About this item
Full title
Author / Creator
Oertel, Wolfgang, Prof , Trenkwalder, Claudia, MD , Beneš, Heike, MD , Ferini-Strambi, Luigi, Prof , Högl, Birgit, MD , Poewe, Werner, Prof , Stiasny-Kolster, Karin, MD , Fichtner, Andreas, Dipl Stat , Schollmayer, Erwin, MD , Kohnen, Ralf, PhD , García-Borreguero, Diego, Dr , on behalf of the SP710 study group and SP710 study group
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Safety and efficacy of non-ergot dopamine agonists for the treatment of idiopathic restless legs syndrome have been shown in short-term trials. We did a prospective open-label extension of a 6-week, double-blind randomised trial to assess the safety, tolerability, and efficacy of rotigotine transdermal patch for up to 5 years in...
Alternative Titles
Full title
Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study
Authors, Artists and Contributors
Author / Creator
Trenkwalder, Claudia, MD
Beneš, Heike, MD
Ferini-Strambi, Luigi, Prof
Högl, Birgit, MD
Poewe, Werner, Prof
Stiasny-Kolster, Karin, MD
Fichtner, Andreas, Dipl Stat
Schollmayer, Erwin, MD
Kohnen, Ralf, PhD
García-Borreguero, Diego, Dr
on behalf of the SP710 study group
SP710 study group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_888112245
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_888112245
Other Identifiers
ISSN
1474-4422
E-ISSN
1474-4465
DOI
10.1016/S1474-4422(11)70127-2
